BeOne Medicines AG
6160.HK News Today: Stay Updated with the Latest BeOne Medicines AG News in Real Time
Find 6160.HK news now at Meyka AI. Stay informed with the latest BeOne Medicines AG stocks updates, including price news, market analysis, and expert insights.
Market Buzz: Bharti Airtel, Coforge, IndiGo, and 5 others Among Top Stocks Today
The Indian stock market is witnessing active trading today as several Top Stocks attract investor attention due to corporate developments, sector growth signals, and broader market sentiment. Shares of Bharti Airtel, Coforge, and IndiGo are among the companies drawing strong interest from traders and institutional investors. Market participants are closely tracking these companies because each…
HIK.L Stock Today: €40m Sintra Investment Boosts EU Output – March 30
Hikma Sintra investment: €40m plan expands EU output from Greater Lisbon, strengthening supply resilience and growth prospects for GB investors in HIK.L. Risks and outlook inside.
Eli Lilly Expands AI Drug Discovery Deal with Insilico Medicine
The pharmaceutical industry is changing fast. And at the center of this shift is Eli Lilly. In March 2026, Eli Lilly expanded its partnership with Insilico Medicine. The deal could reach $2.75 billion, making it one of the biggest AI-driven drug discovery agreements so far. We from the healthcare and tech space view this as…
Sai Parenteral IPO: How to Check Allotment Status and Latest GMP
The Sai Parenteral IPO closed for subscription on March 27, 2026, and investors are now closely watching the allotment, expected on March 30, 2026. The ₹400+ crore issue saw moderate demand, with stronger interest from institutional investors than retail buyers. At the same time, the Grey Market Premium (GMP) has remained flat, signaling cautious market…
Hong Kong March 30: Cheuk Wing-hing Sets Re-entry Rules for Estate
Cheuk Wing-hing sets Hong Kong estate re-entry 规则 after a major outage. One-time access, movers barred, hygiene risks flagged. Social Welfare Department to assess residents and provide support. Clear,
NITI Aayog March 29: Probiotics, Generics, AI Signal Health Upside
NITI Aayog probiotics focus signals upside for India’s FMCG, pharma, and healthtech. Evidence-based products, wider generics, and AI-driven digital health may reshape growth.
NITI Aayog March 29: Gut Health Warning Puts Probiotics, Digital Care in Focus
NITI Aayog probiotics warning spotlights gut health, evidence-based products, digital health India, and generic medicines policy. We map investor catalysts, risks, and policy signals for India’s nutri
Novartis to Acquire U.S. Biotech Firm Excellergy in Deal Worth Up to $2 Billion
Swiss pharmaceutical giant Novartis announced plans to acquire the U.S. biotech company Excellergy in a major strategic deal valued at up to $2 billion. The acquisition aims to expand Novartis’s drug development pipeline and strengthen its position in innovative therapies. Market watchers believe the transaction could have significant effects on the broader stock market and…
Merck Close to $6 Billion Deal to Acquire Terns Pharma, FT Says
Global pharmaceutical giant Merck is reportedly nearing a major acquisition worth nearly $6 billion, according to a Financial Times report. The deal involves U.S.-based biotech company Terns Pharmaceuticals and reflects a broader shift in the healthcare industry as large drugmakers race to strengthen their future drug pipelines. The potential acquisition has already sparked strong reactions…